Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Danaher Preliminary Q1 Revenues Grow 3 Percent; Firm Withdraws 2020 Guidance

Danaher Preliminary Q1 Revenues Grow 3 Percent; Firm Withdraws 2020 Guidance

Apr 13, 2020
|
staff reporter

NEW YORK – Danaher reported on Monday it expects preliminary revenue growth of 3 percent year over year for the first quarter of 2020.

Non-GAAP core revenue growth is expected to be approximately 5 percent.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Keep It (Partly) Virtual

A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.

For Cross-Protection

Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.

Proteomics of Severity

Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.

Genome Biology Papers on Regulatory Element, Single-Cell Integration, Sequence Simulation Tools

In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.

What's Popular?

In Business News

  1. Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

  2. Twist Bioscience, Watchmaker Genomics Partner on High-Throughput NGS Applications

  3. Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

  4. Olink Files For Public Offering in US

  5. Quidel Stock Plunges in February as GenomeWeb Index Falls 3 Percent

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.